NCT06353750View on ClinicalTrials.gov

Intracellular Magnesium and Heart Failure

Not yet recruitingOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

April 25, 2026

Conditions
Heart Failure With Preserved Ejection FractionHypomagnesemia
Interventions
OTHER

Magnesium supplement

Intravenous magnesium supplement (10mmol).

Trial Locations (1)

OX3 9DU

Oxford Centre for Magnetic Resonance (OCMR), Oxford

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

collaborator

Oxford University Hospitals NHS Trust

OTHER

lead

University of Oxford

OTHER

NCT06353750 - Intracellular Magnesium and Heart Failure | Biotech Hunter | Biotech Hunter